1. |
[J]. J Clin Endocrinol Metab, 1997; 82(2)∶421.
|
2. |
[J]. Metabolism, 1996; 45(4)∶450.
|
3. |
王洪濤, 區慶嘉, 劉曉平, 等. 重組生長激素對實驗性肝硬變肝細胞生長激素受體表達的調控作用 [J]. 中華普通外科雜志, 2002; 17(2)∶ 93.
|
4. |
丁銳, 曹海國, 倪泉興. 重組生長激素在外科領域的應用 [J]. 中國實用外科雜志, 2001; 21(6)∶332.
|
5. |
黃伯高, 廖鎮江, 劉琰. 重組生長激素對燒傷創面愈合的影響 [J]. 上海第二醫科大學學報, 2000; 20(1)∶49.
|
6. |
于杰, 陳文郁, 吳詩品. 重組生長激素治療肝硬變低蛋白血癥的臨床研究 [J]. 臨床消化病雜志, 2001; 13(4)∶156.
|
7. |
蔣俊康, 任進民. 應高度重視白蛋白制劑所致的不良反應 [J]. 中國醫院藥學雜志, 1994; 14(10)∶46.
|
8. |
Rothschild MA, Oratz M, Schreiber SS. Serum album [J]. Hepatology, 1988; 8(2)∶385.
|
9. |
Hermansson M, Wickelgren RB, Hammarqvist F, et al. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reactionbased assay: demonstration of reduced expression after elective surgery.
|
10. |
何桂珍, 蔣朱明. 重組人生長激素對創傷后代謝的影響 [J]. 中華醫學雜志, 1995; 75(5)∶312.
|
11. |
Jeevanandam M, Holaday NJ, Petersen SR. Adjuvant recombinant human growth hormone does not augment endogenous glucose production in total parenteral nutritionfed multiple trauma patients.
|